Tag Archives: Scottsdale Healthcare

TGen fundraising event moves to Scottsdale

The 9th annual stepNout Run, Walk Dash, a major fundraising event for pancreatic cancer research at the Translational Genomics Research Institute (TGen), is moving to the Scottsdale Sports Complex.

More than 1,000 participants have attended stepNout in each of the past few years, and even more are expected to attend this year’s morning-long event on Nov. 2 in Scottsdale, featuring fun, competitive races for all ages and abilities, including the event’s signature 5K run.

“We are thrilled to announce that our enormously successful stepNout event will come to the City of Scottsdale. By partnering in this new way with the City of Scottsdale, TGen is generating answers and hope in the search for new treatments for patients with pancreatic cancer,” said TGen Foundation President Michael Bassoff.

Vowing to “fight pancreatic cancer, one step at a time,” stepNout organizers plan to raise more than $150,000 this year on the way to eventually surpass the $1 million mark in fundraising. Participants have donated more than $750,000 since the event started in 2006 at Kiwanis Park in Tempe.

One of TGen’s goals is to develop a method of early detection for pancreatic cancer. Currently, there are no tests to catch this disease in its early stages. As a result, it often is not diagnosed until its late stages, making it more difficult to treat.

Pancreatic cancer this year will take the lives of nearly 40,000 Americans, the nation’s fourth-leading cause of cancer-related death.

TGen’s pancreatic cancer research is led by Dr. Daniel D. Von Hoff, TGen’s Distinguished Professor and Physician-In-Chief, and Chief Scientific Officer for the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with TGen.

Dr. Von Hoff is recognized as one of the world’s leading authorities on pancreatic cancer. He and his team have helped develop three different treatment regimens to improve survival for people with advanced pancreatic cancer. If applied earlier, these regimens have the potential to make an even more powerful impact against the disease.

“We are proud to add stepNout to the calendar of exciting and meaningful events that call Scottsdale home. TGen is one of the most significant contributors to Scottsdale’s Cure Corridor of research and medical facilities, offering world-class healthcare opportunities to residents of Scottsdale and all Arizona citizens,” said Scottsdale Mayor W.J. “Jim” Lane.

Scottsdale Sports Complex, 8081 E. Princess Drive, is a state-of the-art, 71-acre competitive sport facility offering tournament level playing conditions. The facility accommodates a variety of flat field sports such as soccer, lacrosse, football, Ultimate Frisbee and rugby. In addition to sports fields, the complex has a lighted basketball court, a shaded playground, multi-use paths, open park space and two restroom facilities.

If you go to stepNout


What: TGen’s 9th annual stepNout Run/Walk/Dash for pancreatic cancer research.
Where: Scottsdale Sports Complex, 8081 E. Princess Drive, northeast of Hayden and Bell roads, between Loop 101 and Frank Lloyd Wright Boulevard.
When: 7-11 a.m. Sunday, Nov. 2. Registration starts at 7 a.m.; races begin at 9 a.m.; an awards ceremony is set for 10 a.m.; and a kids’ dash is planned for 10:30 a.m.
Cost: Registration fees range from $15 to $35, depending on age and competition. Children ages 4 and under are free.

Registration: Register at the event, or register online by Oct. 28 by visiting www.tgenfoundation.org/step.
Parking: Free.

Brigadier General Scott L. Pleus, Commander, 56th Fighter Wing Air Education and Training Command at Luke Air Force Base was keynote speaker at the graduation for the inaugural class of Scottsdale Healthcare’s U.S. Air Force Critical Care and Emergency Trauma Nursing Fellowship.

Air Force nurses complete inaugural trauma fellowship

Three Air Force nurses became the first graduating class of the Scottsdale Healthcare-U.S. Air Force Critical Care & Emergency Trauma Nursing Fellowship at Scottsdale Healthcare Osborn Medical Center on Aug. 7.

The 12-month program includes five weeks of in-depth classroom education followed by hands-on learning with preceptors in the specialty care units and Level I Trauma Center at Scottsdale Healthcare Osborn Medical Center. Air Force nursing fellows also complete rotations for experience in areas such as burn ICU, pediatric ICU and prehospital care at affiliated sites.

The inaugural Fellowship class graduates were Capt. Patrick Nugent of Sparta, Wis., Capt. Weston Winn of Knoxville, Tenn. and 1st Lt. Katrina Chu of New York, New York. Major Susie Everly, whose experience ranges from multiple deployments as an aeromedical evacuation nurse to serving as the Senior White House Nurse, is director of the Fellowship.

Based in the Military Training Center at Scottsdale Healthcare Osborn Medical Center, the Fellowship is the only one of its kind in a civilian hospital, and one of only two Air Force Nursing Fellowship programs in the U.S.

Brigadier General Scott L. Pleus Commander, 56th Fighter Wing, Air Education and Training Command, Luke Air Force Base, Arizona Unit was keynote speaker. He commended the graduates and the program for providing needed skills to care for injured military personnel in the field worldwide.

“By the end of the fellowship, these nurses emerge as experienced critical care and emergency trauma nurses with the education, clinical skills and confidence to care for the highest acuity patients,” said Jerry Zabokrtsky, director of Corporate & Community Preparedness for Scottsdale Healthcare.

Contributing more than $1 million annually to the Scottsdale economy, the Scottsdale Healthcare Military Partnership provides military medical personnel with training, education and the clinical experience needed to perform successfully in combat and humanitarian missions while building relationships that can be used in potential disaster response situations. To date, more than 2,100 service members have been trained.

Scottsdale Healthcare is an affiliate of Scottsdale Lincoln Health Network, and includes Scottsdale Healthcare Shea Medical Center, Scottsdale Healthcare Thompson Peak Hospital and Scottsdale Healthcare Osborn Medical Center, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Primary Care centers, Scottsdale Healthcare Research Institute and other services. For more information, visit www.shc.org.

36fdb1a35cd2f54f95cf2119fb5bc7ed_XL

Scottsdale Healthcare Shea in ’100 Great Hospitals’

Scottsdale Healthcare Shea Medical Center was recently named one of the “100 Great Hospitals in America” by healthcare industry trade publication Becker’s Hospital Review.

With its selection of Scottsdale Healthcare Shea Medical Center, the editorial team from Becker’s noted several positives including surgical expertise, patient safety, education and research capabilities.

Editors also highlighted the hospital’s orthopedic programs and involvement in drug development research through the Virginia G. Piper Cancer Center and Scottsdale Healthcare Research Institute, which led to new treatments for advanced pancreatic cancer and basal cell carcinoma being approved by the U.S. Food and Drug Administration.

Scottsdale Healthcare Shea Medical Center is one of the economic anchors of the city of Scottsdale’s Cure Corridor along Shea Blvd. near Loop 101. The 433-bed medical center is designated as a Magnet hospital for nursing excellence by the American Nurses Credentialing Center.

“This recognition is for the dedicated team of physicians, staff, volunteers and leaders who provide the care, support, research and resources that make honors like this possible,” said Gary Baker, chief executive officer of Scottsdale Healthcare Shea Medical Center. “We do not go about our work seeking these recognitions; it is truly a byproduct of the wonderful team that provides care in this community.”

To develop its list, the Becker’s Hospital Review editorial team conducted research, considered nominations and evaluated reputable hospital resources such as Truven Health Analytics, Healthgrades, American Nurses Credentialing Center, The LeapFrog Group and other resources.

“Defining a hospital today, let alone a great hospital, has become an unusual sort of challenge. A hospital is no longer just a facility where people go to have a baby or undergo surgery. It’s become an organization that coordinates care for the masses and ensures patients stay healthy in the future,” editors noted in announcing the 2014 “100 Great Hospitals in America” list.

According to Becker’s Hospital Review, each of listed institutions has a rich history, strong credentials and a growing focus on how to best care for patients in an era of reform. “These organizations have played home to some of the greatest medical advancements in U.S. healthcare history, and they are also the bastions of their respective communities — serving the roles of academic hubs or local mainstays,” said Becker’s editors.

Scottsdale Healthcare is an affiliate of Scottsdale Lincoln Health Network, and includes Scottsdale Healthcare Shea Medical Center, Scottsdale Healthcare Thompson Peak Hospital and Scottsdale Healthcare Osborn Medical Center, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Primary Care centers and the Scottsdale Healthcare Research Institute. For more information, visit www.shc.org.

medical.research

TGen, SHC begin clinical trial for anti-tumor drug

The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, especially those with brain tumors and gallbladder bile duct cancer.

“AG-120 is designed specifically for those patients who carry the IDH1 gene mutation,” said Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief at TGen, and Chief Scientific Officer for the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and TGen that delivers new treatments to cancer patients based on precision medicine.

The IDH1 gene mutation is most commonly found in gliomas, which make up the largest group of “primary” brain tumors, those that start in the brain. Gliomas include all tumors arising from the gluey or supportive tissue of the brain. They represent about 30 percent of all brain tumors, and about 80 percent of all malignant brain tumors.

As with all brain cancers, gliomas are difficult to treat and many grow back after surgery, radiation and standard of care chemotherapy. Many drugs cannot get to the brain because of a filtering mechanism in the body called the blood-brain barrier.

“There is a great need for more effective treatments for patients with gliomas and other solid tumors, such as gallbladder bile duct cancer,” said Dr. Von Hoff, who is the Principal Investigator for AG-120 clinical trial. This study will enroll as many as 50 patients. Researchers will use precision medicine to match treatments to patient’s specific genomic, or molecular, makeups.

Mutations in isocitrate dehydrogenase (IDH) 1 and 2, originally discovered in 2008, occur in the vast majority of low-grade gliomas and secondary high-grade gliomas. IDH mutations are oncogenic, meaning they have the potential to cause cancer. These mutations occur early in the formation of gliomas and in gallbladder bile duct cancer.

AG-120 is produced by Agios Pharmaceuticals Inc., based in Cambridge, Mass.

IDH1 is a metabolic enzyme identified by Agios as a protein that is mutated in a wide range of malignant tumors. Agios and its collaborators recently demonstrated that IDH1 mutations initiate and drive cancer growth by blocking differentiation, or maturation, of primitive cells. According to Agios, the inhibition of these mutated proteins may lead to clinical benefit for those cancer patients whose tumors carry them.

bioscience

Pancreatic cancer drug successfully tested by TGen

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM-398, given in combination with 5-flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously-treated pancreatic cancer.

The NAPOLI-1 (NAnoliPOsomaL Irinotecan) Phase 3 study — a final confirmation of a drug’s safety and effectiveness — was conducted among patients with metastatic pancreatic cancer who previously received gemcitibine, which has been the standard-of-care therapy for such patients.

The study, sponsored by Merrimack Pharmaceuticals, evaluated 417 patients enrolled at more than 100 sites in North America, South America, Europe, Asia and Australia, including patients at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. Merrimack expects to submit a New Drug Application this year to the U.S. Food and Drug Administration (FDA) for the MM-398 combination regimen.

“This demonstration of a survival benefit from the MM-398 plus 5-FU and leucovorin combination is particularly important given that we have very few treatment options for patients in this tough clinical setting,” said Dr. Daniel D. Von Hoff, MD, FACP, global principal investigator of the NAPOLI-1 study, Chief Scientific Officer for Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials and Physician-In-Chief and Distinguished Professor at TGen. “The results of the NAPOLI-1 study are important because of the critical need to help patients with this devastating illness and move forward towards FDA approval.”

The combination of MM-398 with 5-fluorouracil (5-FU) and leucovorin achieved an overall survival of 6.1 months, a 1.9 month improvement over the 4.2 month survival demonstrated by the control arm of 5-FU and leucovorin alone.

Each year in the U.S., nearly 46,000 people are diagnosed with pancreatic cancer, and more than 39,000 patients die, making it the fourth leading cause of cancer death. Only about 1 in 4 patients survive more than one year after diagnosis, and only 6 percent survivor more than five years.

Symptoms of pancreatic cancer usually do not appear until the cancer is in its late stages, making it difficult to treat. Once the disease spreads to other parts of the body, most patients are not candidates for surgery and receive chemotherapy as their primary treatment.

This study will be presented at the European Society for Medical Oncology World Conference on Gastrointestinal Cancer being held June 25-28 in Barcelona, Spain.

Patients seeking information about research studies may contact the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare at 480-323-1339 or toll free at 1-877-273-3713 or e-mail: clinicaltrials@shc.org.

cancer

Scottsdale Healthcare cancer programs honored

The cancer programs at Scottsdale Healthcare Osborn Medical Center and Scottsdale Healthcare Shea Medical Center, including the Virginia G. Piper Cancer Center at Scottsdale Healthcare, have been awarded the 2013 Outstanding Achievement Award by the American College of Surgeons’ (ACS) Commission on Cancer (CoC).

The award acknowledges cancer programs that achieve excellence in providing quality care to cancer patients. Scottsdale Healthcare has the only two cancer programs in Arizona and is among a select group of 74 healthcare facilities across the U.S. to receive the CoC national Outstanding Achievement Award.

“This award is a reflection of the dedication and expertise of our cancer care team, who have dedicated their careers to caring for cancer patients and work tirelessly to provide comprehensive, high quality and compassionate care to our patients,” said Gary Baker, Scottsdale Lincoln Health Network senior vice president and CEO of Scottsdale Healthcare Shea Medical Center.

Scottsdale Healthcare’s cancer programs were evaluated on 34 standards categorized within five activity areas: clinical services, quality improvement, cancer committee leadership, cancer data management and cancer conferences. Eligibility for the Outstanding Achievement Award requires achieving a rating of compliance in each of the 34 standards and a rating of commendation in seven additional standards.

“We are proud of this honor,” said Selma Kendrick, director of operations for the Virginia G. Piper Cancer Center at Scottsdale Healthcare. “It’s an important accomplishment because it recognizes our dedication to providing world-class cancer care for our patients through a variety of disciplines and the high standards we have operationally.”

According to the Commission on Cancer, the purpose of the award is to raise awareness on the importance of providing quality cancer care at healthcare institutions throughout the U.S. In addition, it is intended to:

• Motivate other cancer programs to work toward improving their level of care.
• Facilitate dialogue between award recipients and healthcare professionals at other cancer facilities for the purpose of sharing best practices.
• Encourage honorees to serve as quality-care resources to other cancer programs.
• Educate cancer patients on available quality-care options.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare opened in 2001 as the first major cancer center in greater Phoenix to offer comprehensive cancer care and research through clinical trials, diagnosis, treatment, prevention and support services in collaboration with leading scientific researchers and community oncologists.

Scottsdale Healthcare Osborn Medical Center, Scottsdale Healthcare Shea Medical Center, Scottsdale Healthcare Thompson Peak Hospital, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Research Institute and related entities are affiliates of the non-profit Scottsdale Lincoln Health Network. For more information on cancer services at Scottsdale Healthcare, visit shc.org. 


The latest graduates of Scottsdale Healthcare’s U.S. Air Force Nurse Transition Program  pose with course supervisors Maj. Darla Mayo and Maj. Tiffanie Rampley.

Air Force RNs complete Scottsdale training

Thirteen active-duty new grad U.S. Air Force nurses graduated April 23 from an advanced clinical training course offered through Scottsdale Healthcare’s Military Training Program.

The nine-week Nurse Transition Program provides hands-on patient care experience for novice U.S. Air Force Air Force nurses at Scottsdale Healthcare Osborn Medical Center and Scottsdale Healthcare Shea Medical Center.

Supervised by Scottsdale Healthcare preceptors, the Air Force nurses mainly work on medical-surgical units within the hospitals and have impact days to further enhance training in areas such as intensive care, emergency department, wound care, laboratory, and the operating room. The Nurse Transition Program is designed to enhance participants’ clinical skills before reporting for duty in military medical facilities.

The 13 graduating nurses bring the total number of graduates to 195 since the Scottsdale Healthcare Nurse Transition Program’s launch in 2009. April graduates and their base assignments include:

Captain Christina Nigro, Wright-Patterson AFB, Ohio; First Lieutenant Paul Reichert, Keesler AFB, Miss.; Second Lieutenant Heather Batt, Joint-Base Langley-Eustis, Va.; Second Lieutenant Holly Fletcher, RAF Lakenheath, England; Second Lieutenant Ellen Frisbie, Fort Sam Houston, Tex.; Second Lieutenant Diana Hudson, Travis AFB, Calif.; Second Lieutenant Amanda Jones, Travis AFB, Calif.; Second Lieutenant Samantha Leonard, Travis AFB, Calif.; Second Lieutenant Emily Plowman, Landstuhl Air Base, Germany; Second Lieutenant Kathryn Polese, Nellis AFB, Nev.; Second Lieutenant Sean Pruett, Joint-Base Langley-Eustis, Va.; Second Lieutenant Rachel Schlink, Travis AFB, Calif.; and Second Lieutenant Elizabeth Shearer – Travis AFB, Calif.

Scottsdale Healthcare is the largest of four Air Force Nurse Transition Program sites across the U.S. in terms of number of participants and the facilities available for use in training. The only other civilian hospitals offering the program are University Hospital in Cincinnati and Tampa General in Florida.

The Nurse Transition Program is part of Scottsdale Healthcare’s partnership with the U.S. Armed Forces. Created in 2004, the military partnership made Scottsdale Healthcare one of the first community hospitals in the United States to welcome all branches of the military for medical training.

Scottsdale Healthcare’s Military Partnership provides training, education and clinical experience for military medical personnel to perform successfully in combat and humanitarian missions while building relationships that can be used in potential disaster response situations. More than 2,000 service members have been trained through the Scottsdale Healthcare Military Partnership.

Michael Gordon MD

Gordon named clinical trials medical director

Michael S. Gordon, MD, one of the greater Phoenix area’s leading medical oncologists and cancer researchers, has been named the new Medical Director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Dr. Gordon will oversee the center’s internationally recognized Phase I clinical trials program, which is known for its leadership in first-in-human studies of new cancer therapies.

Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with TGen, is a leading clinical research site for Phase I studies of new cancer drugs. It is often among the first in the world to offer a new investigational drug for eligible patients with a broad range of cancers.

Dr. Gordon is a medical oncologist who serves as CEO of Pinnacle Oncology Hematology, a division of Arizona Center for Cancer Care, in Scottsdale, focusing on translational research and the care and management of cancer patients seeking phase I and phase II clinical trials. He is a Clinical Professor of Internal Medicine at the University of Arizona College of Medicine in Phoenix, and is actively engaged in the education of medical students as co-director of the Oncology Block.

Dr. Gordon’s principal research interests are in development of new cancer therapies with a focus on targeted and immunologic therapies as well as drugs that affect angiogenesis (tumor blood vessel supply). Avastin®, Perjeta® and Neumega® are among the drugs Dr. Gordon has helped validate for FDA approval. His disease focuses include kidney cancer, melanoma, prostate cancer, lung cancer, gastrointestinal stromal tumor (GIST) and ovarian cancer.

Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, through its relationships with top physician scientists, biotechnology and pharmaceutical companies world wide, offers a variety of early-phase cancer research studies providing local impact to the citizens of Arizona, according to Dr. Gordon.

“The care and management of patients with cancer and associated diagnoses is rapidly evolving. The ability to provide patients with cutting-edge treatments has the potential to transform the way cancer care is delivered. The Virginia G. Piper Cancer Center at Scottsdale Healthcare has always been a leader in this regard and its relationships with its community partners defines Scottsdale Healthcare’s commitment to our patients and our community,” said Dr. Gordon.

“I look forward to working with my colleagues and to the evolution of a new dynamic as we work to accelerate the access to new cancer drugs to our patients in need. By focusing on innovation in a collaborative spirit with our community physicians, we reinforce our primary commitment to our patients and their families,” he continued.

Dr. Gordon specifically noted the strength of the talent in Scottsdale and their commitment to excellence. “Our programs have a tremendous core of individuals at all levels of clinical research and primary patient care who ensure that we do the best work possible, drawing greater focus on Scottsdale as the “go to” place for cancer drug development.”

The Virginia G. Piper Cancer Center at Scottsdale Healthcare and Scottsdale Healthcare Research Institute are known for collaborations with leading genomic scientists, academic centers and community-based physicians such as the Arizona Center for Cancer Care, Palo Verde Hematology Oncology and Arizona Oncology Associates, said Mark Slater, PhD, chief executive, Scottsdale Healthcare Research Institute.

“We will continue to collaborate with our community physicians, our partners at the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2), nationally recognized universities and others to better serve our community and accelerate breakthrough innovations for cancer treatment,” added Dr. Slater.

Examples of recent successes in accelerating new drug development at the Virginia G. Piper Cancer Center are skin cancer drug Erivedge® and the use of Abraxane for treating pancreatic cancer. Both worldwide studies were led in Scottsdale by Daniel D. Von Hoff, MD, chief scientific officer of the Virginia G. Piper Cancer Center at Scottsdale Healthcare and TGen Physician-in-Chief.

The U.S. Food and Drug Administration approved Erivedge® for advanced basal cell carcinoma in January 2012 and approved Abraxane in combination with standard therapy for pancreatic cancer in September 2013.

“We are honing in on the pathways to help tailor the right drug to the right patient at the right time,” said Dr. Von Hoff. “This is an exciting era of precision medicine and the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare provides unprecedented access to new therapies for people in our community.”

Ramesh Ramanathan, MD, an investigator at Virginia G. Piper Cancer Center Clinical Trials specializing in treatment of gastrointestinal cancers, agreed that the program will benefit from the inclusion of Dr. Gordon.

“My passion is cancer research and I look forward to growing our program along with Dr. Gordon, Dr. Von Hoff and everyone involved in this important work at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. I’m optimistic that we can continue our strong track record of success as we battle this disease,” said Dr. Ramanathan, who is also a senior investigator and Clinical Professor at TGen and the University of Arizona College of Medicine in Phoenix.

“Our campus is becoming the epicenter of research activity across the Scottsdale Lincoln Health Network, and we are creating an infrastructure that continues to attract top talent to our organization,” added Gary Baker, senior vice president and CEO, Scottsdale Healthcare Shea Medical Center.

Baker noted that the depth of science through the diagnostic and genomic capabilities available to local cancer patients is a key benefit of the inclusiveness and collaborative spirit fostered within the Scottsdale Healthcare Research Institute.

“It’s a great example of locally based, yet nationally respected leading researchers, community physicians and clinical teams working together to develop new therapies and innovative treatments that benefit patients here in Arizona and across the United States,” concluded Ron Korn, MD, PhD, medical director of the Virginia G. Piper Cancer Center at Scottsdale Healthcare.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare opened in 2001 as the first major cancer center in greater Phoenix, offering comprehensive cancer care and research through Phase I clinical trials, diagnosis, treatment, prevention and support services in collaboration with leading researchers and community oncologists.

Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare is known worldwide for its expertise in studying new treatments for pancreatic cancer. It is a co-lead site with Dr. Von Hoff as the principal investigator for Stand Up to Cancer’s Pancreatic Cancer Dream Team comprised of scientists working to develop new treatments for pancreatic cancer.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare, an affiliate of the Scottsdale Lincoln Health Network, is designated by the Association of Community Cancer Centers as a Community Resource Center for Pancreatic Cancer and holds Accreditation with Commendation from the Commission on Cancer of the American College of Surgeons.

10258873_934794563202520_1916243681706580952_o

Az Business honors healthcare leaders

Each year, Az Business magazine hosts the Healthcare Leadership Awards to honor the women, men and institutions that bring excellence and innovation to Arizona’s healthcare system. Here are the winners and finalists who were chosen by a panel of industry experts and were recognized at the 2014 Healthcare Leadership Awards on Thursday, April 10 at the Ritz Carlton in Phoenix. See photos from the event here or on our Facebook page.

BIOSCIENCE COMPANY
Winner: Translational Genomics Research Institute (TGen)
TGen has made great strides in the field if genomics medicine. TGen researchers work to help physicians prescribe drugs that are designed more intelligently, work more effectively and have fewer toxic side effects. They have received numerous grants to support research into brain cancer and brain injuries, advanced cancers, Parkinson’s, rare childhood disorders, and more.

Finalists:
Barrow at PCH
Sonora Quest

COMMUNITY OUTREACH/EDUCATION
Winner: Barbara Kavanagh, Arizona Myeloma Network
Kavanagh’s mission is to change the lack of information and support resources for myeloma cancer by forming the Arizona Myeloma Network and the Living with Myeloma Conference, which has grown to 300 people. She also introduced the Pat and Bill Hite Cancer Caregivers Education and Support Program for caregivers to receive support and answers.

Finalists:
Catherine Ivy, Ben and Catherine Ivy Foundation
Kathleen Goeppinger, Ph.D., Midwestern University

HEALTHCARE EXECUTIVE
Winner: Robert L. Meyer, Phoenix Children’s Hospital
Meyer is credited for the rapid and significant turnaround of Phoenix Children’s Hospital from the edge of financial failure to a successful $588 million expansion that made the hospital into one of the largest pediatric medical centers in the country. PCH is ranked in U.S. News & World Report’s Best Children’s Hospitals.

Finalists:
Tim Bricker, Chandler Regional and Mercy Gilbert
Mary Lee DeCoster, Maricopa Integrated Health System
Tony Marinello, CEO of Mountain Vista, IASIS Healthcare
Ed Myers, St. Luke’s Medical Center, IASIS Healthcare

HEALTHCARE ADVOCATE
Winner: Dr. John Chen, Maricopa Integrated Health System
Serving the community’s most vulnerable residents, Chen has helped thousands of patients within the Maricopa Integrated Health System. He sees patients who are in urgent need of treatment because of their lack of dental insurance or location in third world countries. He promotes dental care and hygiene to help prevent serious diseases.

Finalists:
Dr. Randal Christensen, Crews ‘n’ Healthcare
Gerri Hether, Orchard Medical Consulting

INSURANCE PROVIDER
Winner: Blue Cross Blue Shield of Arizona
Marking its 75th anniversary in Arizona, BCBSAZ is committed to improving the quality of life for all Arizonans. The company focuses on providing the best value in health insurance as well as outside programs targeted to children and their families to help reduce childhood obesity.

Finalists:
Health Net of Arizona
UnitedHealthcare of Arizona

LEGAL ADVOCATE
Winner: Kristen Rosati, Polsinelli
As an attorney dedicated to the healthcare industry, especially to healthcare privacy, health information exchange and clinical research, Rosati has written 12 books, 30 articles and made 200 presentations on healthcare topics. She also helped establish two nonprofits in Arizona that support health information exchange and health information technology.

Finalists:
Richard Mallery, Snell and Wilmer
Martin L. Shultz, Brownstein Hyatt Farber Schreck

MEDICAL CENTER OR HOSPITAL
Winner: Scottsdale Healthcare
As a nonprofit, Scottsdale Healthcare not only employs 6,500 staff members, but also is comprised of 1,400 volunteers who donate more than 155,000 hours of service each year. They are the largest employer in the City of Scottsdale and is known for its innovative medical technology, research and patient care.

Finalists:
Banner Good Samaritan Medical Center
Cancer Treatment Centers of America
St. Joseph’s Medical Center
St. Luke’s Medical Center

MEDICAL COMPANY OF THE YEAR
Winner: Ventana
Ventana is driving personalized healthcare through the development of “companion diagnostics” to identify patients most likely to respond favorably to specific therapies. Ventana has worked is currently engaged in more that 150 collaborative projects to develop and commercialize companion diagnostics globally.

Finalists:
Medtronic
W.L. Gore and Associates

MEDICAL RESEARCH COMPANY
Winner: Banner Alzheimer’s Institute
BAI has undergone a major prevention trial to evaluate a treatment in cognitively healthy older adults at the highest known genetic risk for developing Alzheimer’s disease at older ages. The study is part of the Alzheimer’s Prevention Initiative API, an international collaboration led by BAI to accelerate the evaluation of promising but unproven prevention therapies.

Finalists:
Banner MD Anderson
University of Arizona Cancer Center

PHYSICIAN OF THE YEAR
Winner: Jimmy Chow, IASIS Healthcare
Chow improved the field of orthopedics by helping to design and teach a hybrid technique of a minimally invasive total hip replacement where the surgeon builds a new hip from inside the body. This surgery results in no post-operative limitations and many patients are discharged within 24 hours. Chow is one of 10 surgeons in the world to perform his surgery.

Finalists:
Karen Corallo Chaney, Magellan Health Services
David Notrica, Phoenix Children’s Hospital

RESEARCHER OF THE YEAR
Winner: Venkatesh G. Ramaiah, Arizona Heart Hospital
Ramaiah, the medical director and director of vascular and endovascular research, successfully created the “un balloon,” which is used to remodel thoracic endografts without the wind sock effect. This products was able to be marketed and sold.

Finalists:
David Jacofsky, CORE Institute
Glen Weiss, CTCA

LIFETIME ACHIEVEMENT
Linda Hunt, Dignity Health
Hunt, who has served as the leader of Dignity Health in Arizona since 2012, has taken a leadership role to advance healthcare and the biosciences for the people of Arizona. She has worked diligently with legislators, business leaders, educators, scientists and community organizations in order to identify, formulate, and support policies that will give Arizonans better healthcare and raise the bar of knowledge.


Click here to see all the photos.

dan-von-hoff

TGen expert honored for cancer research

Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research.

Dr. Von Hoff, M.D., FACP, who is Physician-In-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGen), and Chief Scientific Officer for Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials, will receive the 2014 Hope Funds Award of Excellence in Medicine.

The Hope Funds for Cancer Research is dedicated to advancing innovative research for the most difficult-to-treat cancers.

Dr. Von Hoff is being recognized for his work over the past decade in the clinical development of many new cancer treatments. He was nominated by past recipients, and selected by the Hope Funds Board of Trustees.

His accomplishments will be celebrated April 24 at the 2014 Award of Excellence Gala at The Metropolitan Museum of Art in New York. The gala provides support for programmatic activities and raises funds for postdoctoral fellowships in cancer research.

Dr. Von Hoff is a medical oncologist and oncology drug developer whose major interest is in the development of new anticancer agents. His clinical research is conducted at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and TGen in Scottsdale, Ariz.

Among the other five recipients of the 2014 Hope Funds Award is Nobel Prize Laureate Dr. James D. Watson, best known as the co-discoverer in 1953 of the double-helix structure of DNA, a scientific turning point in the understanding of life. Dr. Watson is receiving a special Award of Excellence for Extraordinary Achievement. Other recipients of this year’s Award of Excellence are: Dr. Tyler Jacks for Basic Science; Dr. Charles L. Sawyers for Clinical Development; and Dr. Jan Vilcek for Advocacy.

“With the occasion to celebrate the greatest living scientist of the 20th Century (Watson) along with this year’s Honorees, plus our past Honorees, this will be a gathering of many of the greatest minds in the field of cancer research,” Dr. Malcolm A.S. Moore, Chairman of the Board of Trustees for the Hope Funds for Cancer Research, said in a press release.

At the gala, Hope Funds will present its Awards of Excellence in recognition of outstanding achievements in the fields of basic research, drug development, medicine, patient support and philanthropy.

“This event, a white tie dinner set in the shadow of an ancient Egyptian temple, will highlight a remarkable group of scientists who are making a radical difference in cancer research. It is truly an extraordinary experience,” Bill Rueckert, Honorary co-chair of the 2014 Gala said in a press release.

Dr. Von Hoff and his colleagues have conducted early clinical investigations of many new cancer agents, including: gemcitabine, docetaxel, paclitaxel, topotecan, irinotecan, fludarabine, mitoxantrone, dexrazoxane, nab-paclitaxel, vismodegib, and others. These treatments are helping many patients with breast, ovarian, prostate, colon, leukemia, advanced basil cell and pancreatic cancers.

“I am truly honored to be included in the company of such distinguished physicians and scientists whose work has been furthered by the Hope Funds for Cancer Research,” said Dr. Von Hoff. “This recognition not only celebrates past accomplishments, but also is a reflection of the advances we are making right now for the benefit of our patients.”

He and his colleagues are concentrating on the development of molecularly targeted therapies for individual patients with cancer. His other major accomplishment is the development of two specific treatments, which have improved the survival for patients with advanced pancreatic cancer.

Dr. Von Hoff also is Professor of Medicine at both Mayo Clinic Scottsdale and the University of Arizona College of Medicine; and Chief Scientific Officer at US Oncology.

Dr. Von Hoff graduated cum laude from Carroll University, and received his M.D. from Columbia University College of Physicians and Surgeons. He completed his internship and residency in internal medicine at the University of California, San Francisco, then completed a medical oncology fellowship at the National Cancer Institute. Dr. Von Hoff served a six-year term on President Bush’s National Cancer Advisory Board (2004-10).

He is a Fellow and past President of the American Association for Cancer Research (AACR), the world’s largest cancer research organization; a Fellow of the American College of Physicians; and a member and past board member of the American Society of Clinical Oncology (ASCO). Dr. Von Hoff is a founder of ILEX™ Oncology, Inc. (acquired by Genzyme after Ilex had 2 agents, alemtuzumab and clofarabine approved by the FDA for patients with leukemia). He received ASCO’s 2010 David A. Karnofsky Memorial Award for his outstanding contributions to cancer research leading to significant improvement in patient care.

dan-von-hoff

SHC’s Von Hoff honored for cancer advances

In association with its 50th anniversary, the American Society of Clinical Oncology (ASCO) has named Daniel D. Von Hoff, M.D., FACP, one of ASCO’s 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care.

Dr. Von Hoff is Chief Scientific Officer for Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials and Physician-In-Chief and Distinguished Professor at Phoenix-based Translational Genomics Research Institute (TGen). He is an internationally recognized physician and scientist whose research during the past 30 years has contributed to the development of many anticancer agents that are routinely used in clinical practice. Among these drugs are fludarabine, mitoxantrone, paclitaxel, docetaxel, irinotecan, topotecan, nelarabine, gemcitabine, vismodegib, and nanoparticle paclitaxel.

ASCO was founded in 1964 by oncologists to improve the care of cancer patients. Profiles of the 50 Oncology Luminaries are being featured on the ASCO website, and their accomplishments will be celebrated at ASCO’s 50th annual meeting, May 30-June 3 in Chicago.

Although it is difficult to pick one highlight of his career, Dr. Von Hoff and his team played an instrumental role in the development of gemcitabine, the first drug to improve the survival of patients with stage IV pancreatic cancer. In 1997, they published the results of a clinical trial that showed that gemcitabine not only increased the rate of clinical benefit in patients with pancreatic cancer compared with fluorouracil (5-FU), but it also improved overall survival.

This work was followed by recognition of the activity of nab-paclitaxel plus gemcitabine against pancreatic cancer with the recent finding that that regimen also improved survival for patients with stage IV pancreatic cancer. On Sept. 6, 2013, the U.S. Food and Drug Administration (FDA) approved nab-paclitaxel as a frontline therapy for patients with advanced pancreatic cancer.

International clinical trials that led to the FDA’s approval were led by Dr. Von Hoff at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership of Scottsdale Healthcare and TGen, at Scottsdale Healthcare Shea Medical Center in Scottsdale, Ariz.

Dr. Von Hoff has also been instrumental in the concept of development of personalized therapy for patients with refractory cancer based on using molecular techniques to profile their cancers. This work included the initial clinical trials to determine what percentage of patients could benefit from that approach.

Dr. Von Hoff has spent the past 30 years of his career leading teams in phase I trials and the development of new therapies, first as the founding director of the Institute for Drug Development at the Cancer Therapy and Research Center in San Antonio, then as the director of the Cancer Center and Professor of Medicine at the University of Arizona. He also is Professor of Medicine at the Mayo Clinic and serves as Chief Scientific Officer for US Oncology.

When Dr. Von Hoff was awarded ASCO’s David A. Karnofsky Memorial Award in 2010, he took several minutes at the beginning of his lecture to memorialize all of the patients that he and his team had lost during phase I trials the previous year, mentioning several of them by name. The gesture reflected what Dr. Von Hoff named as the greatest accomplishment of his career: working hard to help as many people as he could.

“I have been extremely fortunate to have many great (and incredibly patient) teachers, mentors, and co-workers,” Dr. Von Hoff said. “Truly though I think the greatest teachers and mentors for me have been those I have been privileged to care for.”

golf

Discount LPGA tix benefit local hospitals

The LPGA Founders Cup has teamed up with Scottsdale Healthcare to donate 100 percent of proceeds to charity from Good Any Day Tickets and Weekly Badges purchased through ScottsdaleHealthcareTickets.org for the LPGA Founder’s Cup, March 18-23 at Wildfire Golf Club at the JW Marriott Desert Ridge Resort and Spa.

The charity ticket program offers a 25% discount on the Good Any Day Tickets  and Weekly Badges. To find the discounted tickets, visit ScottsdaleHealthcareTickets.org and scroll down to General Ticket options, and select either Any Day Grounds (SHC) of Weekly Badge (SHC).

Proceeds from tickets purchased through ScottsdaleHealthcareTickets.org will benefit patient care in the nonprofit Scottsdale Healthcare hospitals serving the Northeast Phoenix and Scottsdale communities. Nearby Scottsdale Healthcare Thompson Peak Hospital is minutes from the tournament site and Scottsdale Healthcare will provide first aid service during the LPGA Founders Cup.

Saturday, March 22 is Scottsdale Healthcare Day at the Founders Cup. Medical professionals from Scottsdale Healthcare will offer free skin cancer and heart health checks for spectators entering the grounds.

“Watch the best women golfers in the world compete at the LPGA Founders Cup at the Wildfire Golf Club at Desert Ridge. All proceeds from this tournament will go to charity,” said LPGA Founders Cup defending champion Stacy Lewis. In 2013, Lewis overcame a three-stroke deficit to win the tournament.

Proceeds from the LPGA Founders Cup benefit the Scottsdale Healthcare Foundation, LPGA Foundation and LPGA-USGA Girls Golf.

Scottsdale Healthcare is a founding partner of the LPGA Founders Cup, and the exclusive outlet for discounted online advance sale tickets, now available at ScottsdaleHealthcareTickets.org.

clear energy systems coming to tempe

Scottsdale Healthcare recognized for energy efficiency

Scottsdale Healthcare’s continuing investment in energy efficiency is paying off, with Arizona Public Service Co. recognizing the local nonprofit hospital system for reduced energy use.

An upgrade to the heating, ventilation and air conditioning systems at the Scottsdale Healthcare Greenbaum Surgery Center last fall resulted in a significant reduction in energy needs and earned a $31,314 rebate from APS, said Dan Evans, facilities manager at Scottsdale Healthcare Osborn Medical Center, where the surgery center is located.

The APS Solutions for Business Program offers rebates based on how much energy may be saved through energy efficient equipment as well as efficiency built into system design, according to Evans.

Scottsdale Healthcare Thompson Peak Hospital also has earned recognition for reducing energy use during peak periods. Scottsdale Healthcare is a longtime participant in this green initiative, said Trevor Swanson, hospital facilities manager.

Scottsdale Healthcare has several other ongoing sustainability programs including:

·         Early adoption of LED lights, which last longer and use less energy.
·         Printing reduction, saving more than 3 million pieces of paper.
·         Recycling of paper, plastic, cardboard, metal, medical sharps and computer parts.
·         On-site document shredding, with more than 290 tons of paper recycled in FY2012.
·         Using electric and/or alternative fuel vehicles.
·         Incentives for staff choosing transportation alternatives: free bus passes, employee van pools, carpool partner-finder program, inter-campus shuttle service, secure lockers for bicycles, compressed work weeks and guaranteed ride home program.

Valley Metro’s Clean Air Campaign named Roman Kludka, a coordinator in Scottsdale Healthcare’s Information Technology department, the 2013 Outstanding Bus Commuter for greater Phoenix. Kludka has logged more than 70,000 miles commuting by bus over 14 years. He’s also covered 14,000 miles walking, for a grand total of 84,000 miles.

145916028

Hospitals' heart attack care earns quality award

The Southwest Alliance for Excellence (SWAE), formerly The Arizona Quality Alliance, today named Scottsdale Healthcare as a 2013 Showcase in Excellence Award winner for the hospitals’ heart attack care process, “Door to Balloon – 60 is the New 90.”

Lowering Door to Balloon (DTB) times helps improve the timeliness of lifesaving therapy for patients with heart attacks who seek care at hospitals that perform emergency angioplasty.

National guidelines target a time of 90 minutes or less from the time a patient enters the ER to receiving balloon angioplasty in a hospital’s cardiac catheterization lab. Scottsdale Healthcare was recognized for improving its performance above and beyond the national target for 100% of patients for the past 16 months.

“This is both impressive and important. It’s about saving lives and improving the quality of life for many people. I’m proud of the teamwork and dedication, and pleased to see it get this kind of recognition,” said Scottsdale Lincoln Health Network President Rhonda Forsyth.

The award follows a recent site visit from Southwest Alliance for Excellence examiners who toured Scottsdale Healthcare hospitals to assess Door-to-Balloon care for heart attack patients.

“They learned about well-coordinated, efficient care that moves heart attack patients rapidly from the ambulance through the Emergency Department and into the cardiac cath lab to open the blocked artery,” said Cheralyn Beaudry, chief quality & patient safety officer for Scottsdale Healthcare.

Examiners heard from the entire team of physicians, nurses, ancillary staff, PBX operators, EMS professionals, service line leaders and quality and lean experts describing how they implemented improvement methods and tools, including A3 thinking, PDSA, standard work, process mapping and process walks, key metrics of performance for each stage of patient care, and ongoing cycles of improvement, according to Beaudry.

Door-to-Balloon times of less than 90 minutes for 100% of patients have been sustained for 16 months now,” explained Beaudry. “With a stated stretch goal of ‘60 is the new 90,’ this team also improved performance above and beyond the national target of less than 90 minutes to complete the DTB process in 60 minutes or less for 50% of cases in the past 12 months,” she said.

“Our DTB team is saving lives, and patients are able to return to a life with more functional potential than was previously possible without this timely evidence-based care,” said Beaudry.  “This is a wonderful example of achieving our mission to provide the highest quality and most compassionate care for all individuals.”

The American College of Cardiology  and the American Heart Association (AHA) state that hospitals treating heart attack patients with emergency angioplasty should reliably achieve a door-to-balloon time of 90 minutes or less. However, accomplishing this level of performance can be an organizational challenge.

“When treating myocardial infarction, every moment that can be saved is critical because it keeps a portion of the patient’s heart muscle from dying due to a lack of oxygen,” says cardiologist Alan Tenaglia, MD. “As we always say, time is muscle.”

SWAE’s annual Performance Excellence Program recognizes organizations for excellence in quality, performance and outcomes.  The program, modeled after the Malcolm Baldrige Award criteria, provides not only an opportunity for recognition, but also valuable feedback on where an organization is positioned on the quality continuum.

Receiving a Showcase in Excellence Award is recognition for specific process excellence, demonstrating innovation, cutting-edge approach, excellence in comparison to peers or overall exceptional performance.

Awards will be presented Feb. 4, 2014 at the Chaparral Suites Resort in Scottsdale.

The Southwest Alliance for Excellence is a 501(c)(3) non-profit corporation that advances improvement and excellence in organizations, communities and individuals throughout Arizona, Nevada and Utah. The SWAE is administered by a professional staff under the leadership and guidance of its members and elected Board of Directors. The SWAE is also a member of the Alliance for Performance Excellence, a national network of state
programs that advance improvement in organizations by using the Baldrige Criteria.

cancer.ytratment

Old Town Scottsdale gets new Cancer Care Center

Arizona Center for Cancer Care (AZCCC), a multispecialty group of Arizona’s most recognizable names in cancer treatment and technology, has announced that it has officially opened at Scottsdale Healthcare’s Osborn Medical Center location.

“We are pleased to welcome AZCCC to the Osborn Medical Center location and look forward to continuing to work together to provide exceptional oncology care at both of our Scottsdale Healthcare facilities,” said Lindsay Thomas, director of oncology for Scottsdale Healthcare.

Earlier this year AZCCC opened a facility at the Virginia G. Piper Cancer Center at Scottsdale Healthcare’s Shea Medical Center location, allowing doctors to accommodate an increased volume of patients and bring leading-edge cancer care technology to Scottsdale Healthcare.

The facility is an outpatient single story building at 337 E. 2nd St. on Scottsdale Healthcare’s Osborn Campus.

“The goal was to bring the best physicians together to offer the best comprehensive care to patients,” said Thomas. “Both the Scottsdale Healthcare Shea and Osborn Centers share a commitment to clinical excellence and our partnership with AZCCC has enabled us to broaden our services in this region.”

Aside from additional exam and procedure rooms, the now complete facility renovations include:
* The addition of state-of-the-art radiation therapy services such as RapidArc Sterotactic Radiosurgery, which will allow for short courses of pin-pointed radiation
* The installation of a new iX Linear Accelerator manufactured by Varian, the industry leader in radiation equipment, capable of delivering precision Intensity Modulated Radiation Therapy (IMRT) and image-guided radiation therapy

“Radiation therapy technologies such as IMRT/ IGRT and Radiosurgery help deliver higher doses of radiation to tumors with fewer complications and less immediate and long-term side effects,” said Dr. Diane C. Racine, a partner at AZCCC and member of the Scottsdale Healthcare medical staff.

Dr. Racine has been providing services at the AZCCC Virginia G. Piper location, but will soon bring her services and expertise to the new facility at the Scottsdale Healthcare Osborn Medical Center. In addition to her current role, Racine practiced at and served as director of residency programs for the Department of Radiation Oncology at Rush-Presbyterian-St. Luke’s Medical Center in Chicago and has both taught radiation oncology courses at the University of Chicago and served as assistant professor of radiation oncology at Rush Medical College.

Joining Racine at the Scottsdale Healthcare Osborn Medical Center will be fellow radiation oncologist Dr. Luci Chen. . Chen also brings experience from her time as clinical director of the Department of Radiation Oncology at Louis A. Weiss Memorial Hospital and as assistant professor of radiation oncology at the University of Chicago. She has also been awarded a Fellowship by the American Cancer Society for her clinical research in cancer care.

“With a coordinated multidisciplinary approach to radiation therapy now available through both Scottsdale Healthcare locations, patients will have the best chance for achieving optimal treatment results with the added convenience of the two local centers,” said Chen.

For more information, please visit www.arizonaccc.com.

Orthopedic surgeon Dr. Ted Firestone and Kelly McCullough, general manager of KAET Channel 8, Arizona’s PBS, with their Emmy Awards for The Latest Procedure: Anterior Total Hip Replacement Surgery.

Emmy Award goes to Scottsdale Healthcare surgeon

Scottsdale Healthcare orthopedic surgeon Dr. Ted Firestone received a Rocky Mountain  Emmy Award from the National Academy of Television Arts and Sciences for The Latest Procedure: Anterior Total Hip Replacement Surgery, produced in collaboration with KAET Channel 8, Arizona’s PBS. The one-hour feature won the award for best informational program at the awards ceremony held at the University of Phoenix Stadium on Oct. 19.

The Latest Procedure took viewers into the operating room at Scottsdale Healthcare Shea Medical Center for a firsthand look at minimally invasive hip replacement surgery. Dr. Firestone, director of Hip Surgery at Scottsdale Healthcare Thompson Peak Hospital, discussed the procedure in detail including the differences and benefits.

The Latest Procedure: Anterior Total Hip Replacement Surgery can be viewed online at AZPBS.org and Dr. Firestone’s website TJRCS.com. The program follows Dr. Firestone as he meets with patients, explains the surgical hardware and offers a tour of the operating room at Scottsdale Healthcare Shea  Medical Center.

Viewers not only scrub in with Dr. Firestone, they get a surgeon’s-eye view of the operation through a mini-cam strapped to his head while he offers a play-by-play description of the operation.

“In my experience, patients undergoing anterior hip replacement versus the conventional posterior surgery leave the hospital a full day earlier. I’ve also found that they experience less post-op pain and require fewer precautions,” added Dr. Firestone.

Only hours after the surgery, Dr. Firestone meets with his patient as she walks down the hallway in the specially designed Total Joint Center at Scottsdale Healthcare Shea Medical Center.

“I’ve been performing anterior hip replacement for five years using a special orthopedic table that allows x-rays to be obtained during the procedure, which helps improve the accuracy of component positioning and leg length determination,” explained Dr. Firestone.

The 2013 Rocky Mountain Emmy Awards were presented Oct. 19 by the Rocky Mountain Southwest Chapter of the National Academy of Television Arts and Sciences. The Latest Procedure: Anterior Total Hip Replacement Surgery was honored in the Informational/Instructional category.

Theodore Firestone, MD, FACS is a board-certified orthopedic surgeon specializing in hip and knee replacement with special emphasis in complex joint reconstruction and revision surgery. He practices exclusively at Scottsdale Healthcare Thompson Peak Hospital.

The Total Joint Centers at Scottsdale Healthcare are specially designed hospital units with a complete pre-operative patient education process to post-operative physical therapy and rehabilitation, with dedicated orthopedic nursing and clinical staff working with patients to accelerate the recovery process.

For more information about joint replacement services at Scottsdale Healthcare, visit shc.org/ortho.

Scottsdale Healthcare is a community-based, not-for-profit health system which includes Scottsdale Healthcare Thompson Peak Hospital, Scottsdale Healthcare Shea Medical Center and Scottsdale Healthcare Osborn Medical Center, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Primary Care centers, Scottsdale Healthcare Research Institute and outpatient services. For more information, visit www.shc.org.

Orthopedic surgeon Dr. Ted Firestone and Kelly McCullough, general manager of KAET Channel 8, Arizona’s PBS, with their Emmy Awards for The Latest Procedure: Anterior Total Hip Replacement Surgery.

Emmy Award goes to Scottsdale Healthcare surgeon

Scottsdale Healthcare orthopedic surgeon Dr. Ted Firestone received a Rocky Mountain  Emmy Award from the National Academy of Television Arts and Sciences for The Latest Procedure: Anterior Total Hip Replacement Surgery, produced in collaboration with KAET Channel 8, Arizona’s PBS. The one-hour feature won the award for best informational program at the awards ceremony held at the University of Phoenix Stadium on Oct. 19.

The Latest Procedure took viewers into the operating room at Scottsdale Healthcare Shea Medical Center for a firsthand look at minimally invasive hip replacement surgery. Dr. Firestone, director of Hip Surgery at Scottsdale Healthcare Thompson Peak Hospital, discussed the procedure in detail including the differences and benefits.

The Latest Procedure: Anterior Total Hip Replacement Surgery can be viewed online at AZPBS.org and Dr. Firestone’s website TJRCS.com. The program follows Dr. Firestone as he meets with patients, explains the surgical hardware and offers a tour of the operating room at Scottsdale Healthcare Shea  Medical Center.

Viewers not only scrub in with Dr. Firestone, they get a surgeon’s-eye view of the operation through a mini-cam strapped to his head while he offers a play-by-play description of the operation.

“In my experience, patients undergoing anterior hip replacement versus the conventional posterior surgery leave the hospital a full day earlier. I’ve also found that they experience less post-op pain and require fewer precautions,” added Dr. Firestone.

Only hours after the surgery, Dr. Firestone meets with his patient as she walks down the hallway in the specially designed Total Joint Center at Scottsdale Healthcare Shea Medical Center.

“I’ve been performing anterior hip replacement for five years using a special orthopedic table that allows x-rays to be obtained during the procedure, which helps improve the accuracy of component positioning and leg length determination,” explained Dr. Firestone.

The 2013 Rocky Mountain Emmy Awards were presented Oct. 19 by the Rocky Mountain Southwest Chapter of the National Academy of Television Arts and Sciences. The Latest Procedure: Anterior Total Hip Replacement Surgery was honored in the Informational/Instructional category.

Theodore Firestone, MD, FACS is a board-certified orthopedic surgeon specializing in hip and knee replacement with special emphasis in complex joint reconstruction and revision surgery. He practices exclusively at Scottsdale Healthcare Thompson Peak Hospital.

The Total Joint Centers at Scottsdale Healthcare are specially designed hospital units with a complete pre-operative patient education process to post-operative physical therapy and rehabilitation, with dedicated orthopedic nursing and clinical staff working with patients to accelerate the recovery process.

For more information about joint replacement services at Scottsdale Healthcare, visit shc.org/ortho.

Scottsdale Healthcare is a community-based, not-for-profit health system which includes Scottsdale Healthcare Thompson Peak Hospital, Scottsdale Healthcare Shea Medical Center and Scottsdale Healthcare Osborn Medical Center, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Primary Care centers, Scottsdale Healthcare Research Institute and outpatient services. For more information, visit www.shc.org.

SurgeryCenter, ORION

ORION Closes Scottsdale Medical Group Lease

Braxton Glass

Braxton Glass

ORION Investment Real Estate recently closed the fee simple interest in one parcel of net leased medical ground in north Scottsdale, Arizona, located within walking distance of Scottsdale’s largest hospital campus.

Scottsdale Healthcare Shea is a 433-bed, full-service hospital providing emergency, medical/surgical, critical care, obstetric, pediatric, cardiovascular, orthopedic and oncology services. All patient rooms are private. Also, on the campus is The Virginia G. Piper Cancer Center and T-Gen at Scottsdale Healthcare, known throughout the southwest for their commitment to providing personalized care and their innovative combinations of community oncology services, academic medicine and genomic research.

The seller, Shea Edward Limited Partnership, sold the 2.17 acres located at 8960 E. Desert Cove Ave. in Scottsdale, on which is located a Surgicenter with 21,674 square feet of ancillary medical offices for $2,100,000 to CMMD 1031, LP and MDCM 1031, LP.  Braxton Glass, Vice President at ORION, represented the Buyer and the Seller in this transaction.

“The unsubordinated structure of the ground lease combined with the exceptional locational characteristics of the parcel create an extremely attractive risk/return profile that is rarely encountered in commercial real estate offerings,” stated Braxton Glass.

Medical Director Mike Janicek, MD, Clinical Manager Sherry Razo and VP/Administrator Kim Post cut the ribbon the dedicate the Women’s Health and Healing Unit at Scottsdale Healthcare Thompson Peak Hospital.

Women's cancer unit dedicated at Thomspon Peak Hospital

Scottsdale Healthcare Thompson Peak Hospital dedicated its new Women’s Health and Healing Unit with a ribbon cutting and celebration for staff.

Located on the hospital’s third floor, it provides a comforting environment to support the needs of women receiving treatment for gynecologic cancers including ovarian, uterine and cervical cancer.

Nursing staff are specially trained in gynecologic cancers and include a dedicated gynecologic oncology-trained Nurse Practitioner, bringing an added layer of care, comfort and expertise to the upgraded and relocated unit.

The Women’s Health and Healing Unit at Scottsdale Healthcare Thompson Peak Hospital was specially decorated to create a warm, soothing environment and designed for enhanced communication among the care team.

“In terms of a medical facility, Scottsdale Healthcare Thompson Peak Hospital is very different and unique. It represents a sanctuary,” says Mike Janicek, MD, medical director of the Women’s Health and Healing Unit and gynecologic oncologist on staff at Arizona Oncology.

“Many of these patients are traumatized and going through a physically and emotionally difficult time,” he explains. “This unit helps with their journey. It’s not as much about the bricks and mortar as it is about the staff and the way they treat patients. The nursing staff, the operating room team – everyone here is phenomenal.”

“It not only has the latest in high-tech equipment, but it’s a very relaxing and comforting place as well. For me and my patients, Thompson Peak Hospital really combines the best of both worlds – the small hospital experience with the medical expertise of a larger facility,” adds Janicek.

Scottsdale Healthcare Thompson Peak Hospital is a leader in minimally invasive surgery – often a major part of the treatment plan in a patient with gynecologic cancer – and is home to the daVinci robotic surgical system, the world’s most technically advanced surgical robot.

And while the state-of-the-art equipment and advanced expertise of the physicians and staff at the hospital are impressive, the calming, patient-friendly atmosphere is also worth noting.

The hospital itself was designed from the patient’s perspective and reflects a new generation of concierge-focused healthcare facilities. Visitors and patients can stroll through the soothing and award-winning healing gardens, shop in the boutique or enjoy works of art created by local artists. Patients can even enjoy a visit from their favorite pet to make them feel more at home and assist in the healing process.

“It truly is the pinnacle of a healing environment. It gives patients such a sense of comfort coming to a place they know and trust,” says Janicek.

Scottsdale Healthcare is a community-based, non-profit health system that includes Scottsdale Healthcare Thompson Peak Hospital, Scottsdale Healthcare Shea Medical Center and Scottsdale Healthcare Osborn Medical Center, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Primary Care centers, the Scottsdale Healthcare Research Institute and other entities. A leader in medical innovation, talent and technology, Scottsdale Healthcare was founded in 1962 and based in Scottsdale, Ariz. For more information, visit www.shc.org.

Medical Director Mike Janicek, MD, Clinical Manager Sherry Razo and VP/Administrator Kim Post cut the ribbon the dedicate the Women’s Health and Healing Unit at Scottsdale Healthcare Thompson Peak Hospital.

Women’s cancer unit dedicated at Thomspon Peak Hospital

Scottsdale Healthcare Thompson Peak Hospital dedicated its new Women’s Health and Healing Unit with a ribbon cutting and celebration for staff.

Located on the hospital’s third floor, it provides a comforting environment to support the needs of women receiving treatment for gynecologic cancers including ovarian, uterine and cervical cancer.

Nursing staff are specially trained in gynecologic cancers and include a dedicated gynecologic oncology-trained Nurse Practitioner, bringing an added layer of care, comfort and expertise to the upgraded and relocated unit.

The Women’s Health and Healing Unit at Scottsdale Healthcare Thompson Peak Hospital was specially decorated to create a warm, soothing environment and designed for enhanced communication among the care team.

“In terms of a medical facility, Scottsdale Healthcare Thompson Peak Hospital is very different and unique. It represents a sanctuary,” says Mike Janicek, MD, medical director of the Women’s Health and Healing Unit and gynecologic oncologist on staff at Arizona Oncology.

“Many of these patients are traumatized and going through a physically and emotionally difficult time,” he explains. “This unit helps with their journey. It’s not as much about the bricks and mortar as it is about the staff and the way they treat patients. The nursing staff, the operating room team – everyone here is phenomenal.”

“It not only has the latest in high-tech equipment, but it’s a very relaxing and comforting place as well. For me and my patients, Thompson Peak Hospital really combines the best of both worlds – the small hospital experience with the medical expertise of a larger facility,” adds Janicek.

Scottsdale Healthcare Thompson Peak Hospital is a leader in minimally invasive surgery – often a major part of the treatment plan in a patient with gynecologic cancer – and is home to the daVinci robotic surgical system, the world’s most technically advanced surgical robot.

And while the state-of-the-art equipment and advanced expertise of the physicians and staff at the hospital are impressive, the calming, patient-friendly atmosphere is also worth noting.

The hospital itself was designed from the patient’s perspective and reflects a new generation of concierge-focused healthcare facilities. Visitors and patients can stroll through the soothing and award-winning healing gardens, shop in the boutique or enjoy works of art created by local artists. Patients can even enjoy a visit from their favorite pet to make them feel more at home and assist in the healing process.

“It truly is the pinnacle of a healing environment. It gives patients such a sense of comfort coming to a place they know and trust,” says Janicek.

Scottsdale Healthcare is a community-based, non-profit health system that includes Scottsdale Healthcare Thompson Peak Hospital, Scottsdale Healthcare Shea Medical Center and Scottsdale Healthcare Osborn Medical Center, the Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Primary Care centers, the Scottsdale Healthcare Research Institute and other entities. A leader in medical innovation, talent and technology, Scottsdale Healthcare was founded in 1962 and based in Scottsdale, Ariz. For more information, visit www.shc.org.

Sun Health

Scottsdale Lincoln Health Network affiliation finalized

Scottsdale Healthcare and John C. Lincoln Health Network, two of the Valley’s most respected locally-based non-profit health systems, have completed the closing documents for a system-wide affiliation to improve the health of communities served by the respective organizations.

The affiliation creates a new non-profit corporate entity, Scottsdale Lincoln Health Network, which will oversee the Scottsdale Healthcare and John C. Lincoln hospitals, clinics, outpatient centers and related services. A Letter of Intent to affiliate was approved by both organizations in April, followed by customary regulatory review processes after a definitive agreement was reached by both organizations in August.

The affiliation does not include the combination of assets and thus is not considered a merger. However management of the affiliated assets will now be vested in a board made up of Scottsdale Healthcare and John C. Lincoln directors.

Both Scottsdale Healthcare and John C. Lincoln Health Network have long histories of high quality care and innovation, are financially sound and now will move forward to create the healthcare organization of the future. What this means for the communities served by John C. Lincoln and Scottsdale Healthcare includes:

·         More convenient access to acute and preventive care.
·         Increased coordination of medical care.
·         An expanded network of high quality primary care and specialty physicians.
·         Creation of a single electronic health record that can be accessed at all levels of care throughout the affiliated health network.
·         Shared best practices.

The new Scottsdale Lincoln Health Network encompasses five acute care hospitals with approximately 10,500 employees, 3,700 affiliated physicians and 3,100 volunteers, an extensive primary care physician network, urgent care centers, clinical research, medical education, an inpatient rehabilitation hospital, an Accountable Care Organization, two foundations and extensive community services.

Tom Sadvary is chief executive officer and Rhonda Forsyth is president of Scottsdale Lincoln Health Network. Steve Wheeler is chairman and Frank Pugh is vice chairman of the Scottsdale Lincoln Health Network Board of Directors.

“Our communities will still receive the same world-class patient care you’ve come to expect from Scottsdale Healthcare and John C. Lincoln Health Network. Our goal is provide excellent, cost-effective care and a patient experience that exceeds your expectations,” said Sadvary.

“The shared vision for our new system is to become a fully integrated, locally controlled, world-class non-profit health system that works effectively to improve our community’s health,” added Forsyth.

Completion of the agreement to affiliate creates a geographically dispersed non-profit healthcare system positioned to             successfully deliver high quality, cost-effective healthcare, according to network leaders.

“Scottsdale Healthcare and John C. Lincoln Health Network both share a commitment to continuing their longstanding support of community health services, health education, disease prevention, screenings and other services,” explained Wheeler.

The combined health organizations are well-positioned to thrive in a rapidly changing healthcare environment, and to embrace the transformation of healthcare delivery that transcends the traditional acute care-centric orientation.

“The affiliation adds value to our ability to serve our patients, and allows us to develop a clinically integrated system of care where physicians, hospitals and other clinicians work in partnership to ensure that patients receive the services they need for the best outcomes,” said Pugh.

Integration planning for the new Scottsdale Lincoln Health Network will continue during the next several months to develop an outline of key priorities, noted Sadvary. The board and senior leadership of the affiliated organization will take a thoughtful and methodical approach to integration planning.

Joanne Clavelle

Scottsdale Healthcare hires new Chief Clinical Officer

Joanne Clavelle, DNP, RN, NEA-BC, FACHE has joined the executive leadership team at Scottsdale Healthcare as senior vice president and chief clinical officer.

Clavelle joins Scottsdale Healthcare after serving as vice president of patient care services and chief nursing officer for St. Luke’s Health System in Boise, Idaho.

Scottsdale Healthcare’s culture – its friendly staff, its focus on patient experience, quality and community, its excellent physicians and commitment to Magnet designation, the gold standard for nursing care – make the new position a great fit, she said.

“I’m excited about the opportunity to work for a health system that is so committed to Magnet,” said Clavelle. “My passion is nursing and delivering outstanding patient care. And with Scottsdale Healthcare’s recent affiliation with John C. Lincoln Health Network, it’s great to see their mutual commitment to Magnet going forward.

“The affiliation presents a wonderful opportunity for expanding access to care and managing population health as we position ourselves for health reform. The synergy and collaboration will be good for the community and good for patients.”

A strong advocate for nurses, Clavelle says they understand the importance of teamwork with physicians and others throughout the care continuum to design systems of care that result in the best outcomes for patients.

“We’re very fortunate to have a chief clinical officer of Joanne’s caliber joining Scottsdale Healthcare,” said Scottsdale Healthcare Executive Vice President and Shea Medical Center Administrator Gary Baker. “I am looking forward to working with her as we enter this new era in our history and work together to care for our community.”

Clavelle’s career began more than 30 years ago as a staff nurse in coronary care and the emergency department. She developed an early interest in preventive healthcare, health promotion and community health improvement.

Clavelle has a Doctorate in Nursing Practice from the Francis Payne Bolton School of Nursing at Case Western Reserve University, is board certified in healthcare administration from the American College of Healthcare Executives and certified in nursing administration-advanced by the American Nurses Credentialing Center.

Her professional background includes staff nurse and nursing leadership positions at Medical Center Hospital of Vermont and vice president of Ancillary Services at Fletcher Allen Healthcare in Burlington, Vermont, and director of Clinical and Community Strategies for VHA Mountain States in Denver. She then became the vice president of Operations at Fletcher Allen Health Care in Burlington, Vermont, before moving to Idaho and joining St. Luke’s Health System – Treasure Valley in Boise.

Nurses in a line

MomDoc Surgeon named to Excellence Team

Dr. Khai Ling Tan, of MomDoc Women For Women, is one of twelve surgeons who perform minimally invasive gynecological procedures to qualify for recognition in excellence in care. The surgeons completed a stringent evaluation process to show they meet established program requirements for providing safe gynecologic care with exceptional short and long term outcomes.

The surgeons distinguished themselves as part of Scottsdale Healthcare’s minimally invasive surgical gynecology program, the first in Arizona to be named a Center of Excellence in Minimally Invasive Gynecology by the American Association of Gynecologic Laparoscopists, the leading association of minimally invasive gynecological surgeons.

“I was fortunate enough to be involved in the process and had the opportunity to witness firsthand how dedicated the hospital is in making patient safety their top priority, says Dr. Tan. “ I feel very privileged to be working with SHC and very proud to be a part of this very prestigious designation.”

The goal of minimally invasive surgery is to reduce patient hospital stays, perform less painful surgeries and have decreased side effects over traditional open-incision surgery. This designation affirms not only evidence based care but the value and safety of minimally invasive procedures.

Scottsdale Healthcare met all ten specific requirements to earn the designation. The select obstetrics and gynecology specialists, Tan amongst them, met all physician requirements. It is an indicator that not only the hospital, but its surgeons are amongst the best in their specialties.

For both the hospital and surgeons it demonstrates consistency and high quality in care and outcomes. It reinforces the belief that instead of focusing on one single aspect of care, the entire system is in a position to deliver the very highest level of care to patients.

Dr. Tan sees patients in the Tempe offices of MomDoc Women For Women, a part of the MomDoc family of practices which includes the Women For Women model of all female providers offering the highest quality and service in caring for all women’s health needs.

Grace 1_M

Scottsdale Healthcare Partners With 12-Year-Old Grace Sinclair to Provide Comfort for Patients

After seeing 12-year old Grace Sinclair’s handmade knit hats she donated to them, Scottsdale Healthcare wanted to ensure that she would keep bringing more. They offered to provide the Glendale resident with the yarn she needed if she would continue knitting and bringing her colorful hats to give to the children at the hospital.

Grace recently began her nonprofit/ministry, “Warming Heads and Hearts by Grace,” after realizing her love for knitting not only hats, but scarves as well, and donating them to those in need. “I’ve always loved giving,” Grace said. She was inspired to keep finding ways to use her talent for knitting after she was able to use the money she made from selling her products to donate it to her young nephew who had been diagnosed with cancer.

Now numerous children have been able to profit from Grace’s generosity. When she brings her big bag full of knitted hats to the hospital, the hats are disinfected to ensure they are safe for the fragile patients. They are then placed into individual bags and set out in a basket in the NICU for parents to come and pick out which one they want for their child.

Grace remembers when she was able to meet a premature baby whose father had picked out one of Grace’s hats for his newly born child to wear. Grace and her father, Doug Sinclair, recall the father of the baby boy being so excited about Grace’s hats because the only ones left provided by the hospital were pink.

Grace has also generously donated her hats to St. Joseph’s Hospital as well as both the NICU and Maternity Floor at Banner Thunderbird Medical Center. Now hospitals all over the state have been contacting Grace about her knitted creations.

But Grace’s giving goes beyond hospitals. She and her family volunteer once a week at a homeless shelter where Grace brings her hats and scarves to hand out during the colder months. She says she loves being able watch the kids pick out which ones they want.

Although she started out by making one or two infant hats in a day, she can now make up to seven. Even though she focuses on hats and scarves, Grace says she wants to try making mittens in the future to donate to people during the winter.

Recently, Grace was formally recognized for her generosity when she received the Kohl’s Cares Award — college scholarship money that Kohl’s awards to kids who are actively serving their community. Although Grace and her unique products are gaining more exposure, she maintains a genuine humility that will carry her far. “It would be her wish to do this for whoever,” said Grace’s father, Doug, “but it’s all about donating. It’s not about marketing or making money.”

Through her handmade hats and scarves, Grace has been able to bring joy to numerous people in difficult situations. Thanks to Scottsdale Healthcare and other supporters, hopefully her products will continue warming many heads and hearts throughout the coming seasons.

Grace 2_M

Knitted Products from “Warming Heads and Hearts by Grace” are distributed at Scottsdale Healthcare and other Valley hospitals.